A new series of pyrano-chromene and pyrimido pyrano-chromene derivatives were synthesized starting from 2-amino-4-(1-naphthyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (6). The structures of the synthesized compounds were elucidated by spectral data. Compounds 6-11, 13-15 and 18 have been selected for an inhibitory activity screening against HIV-1 and HIV-2 in MT-4 cells.
Introduction
Chromenes and coumarins [1] have been the subject of considerable chemical interest in the past decades. They occur widely in nature and exhibit important biological as well as pharmacological activities [2 -5] . Among chromene derivatives are biologically interesting compounds showing antimicrobial [6 -10] and antifungal activities [11, 12] , inhibitors of influenza virus silidoses [13, 14] , compounds with antihypertensive [15] and anti-allergic activity [16] and hair growth stimulant properties [17] . However, the chromenes are also well known for their biocidal [18, 19] , wound healing [20] , anti-inflammatory [21] , and antiulcer [22] activities.
Some fused chromene derivatives were found useful as antiviral [23] , antiproliferation [24] , antioxidative [25, 26] , antileishmanial [27] , antitumor [28] , and anti-HIV agents [29] , show central nervous system (CNS) activities [30] , and find application in the treatment of Alzheimer's disease [31] and Schizophrenia disorder [32] . Satyanarayana et al. [33] reported the synthesis and antifungal screening of new Schiff bases of chromenes under conventional and microwave conditions. Furthermore, Lee et al. [34] have synthesized 3 R, 4 
R-di-(O)-(−)-camphanoyl-2 ,2 -dimethyldihydropyrano[2,3-f ]chromone (DCP)
(1) as a potent in vitro inhibitor of HIV-1 replication in H9 lymphocyte cells with an EC 50 of 6.78 × 10 −4 µM. The family of 4-aryl-4H-chromenes has been recently reported to possess anti-cancer activity. These compounds, which are potent apoptosis inducers (e. g. compound 2), were found to be highly active in the growth inhibition MTT with the concentration causing 50 % cell growth inhibition (IC 50 ) values in the low nanomolar range [35] . Geiparvarin (3), a naturally occurring compound bearing a coumarin residue, has been shown to possess a significant inhibitory activity against a variety of cell lines including sarcoma 180, Lewis lung carcinoma, P-388 lymphocytic leukaemia, and Walker 256 carcinosarcoma [36] .
In the present paper, we report the synthesis of new chromene derivatives and their in vitro activity on the replication of HIV-1 and HIV-2.
Results and Discussion
A number of synthetic strategies have been reported for the construction of chromenes, for example, construction of the chromene ring by a twostep sequence, typically involving prefunctionalization of the arene (e. g., halogenation at the 2-position) followed by Heck-type cyclization [37 -41] . In the present study, we report on the synthesis of 2-amino-4-(naphthalen-1-yl)-5-oxo-4H,5H-Scheme 1. Synthesis of chromene-3-nitrile (6), chromen-2-yl-formimidate (7), 8,9-dihydrochromeno-pyrimidin-6-one (8) and (9) , and phenylchromeno-pyrimidin-6,8-dione (10) derivatives. pyrano[3,2-c]chromene-3-carbonitrile (6) via reaction of (1-naphthylmethylene)malononitrile (4) and 4-hydroxycoumarin (5). Compound 6 was selected as a key intermediate for the synthesis of new fused and non-fused chromene derivatives, aiming at an evaluation of their anti-HIV activity. Thus, treatment of 6 with triethyl orthoformate in acetic anhydride gave the corresponding formimidate derivative 7 in 69 % yield. Benzoylation of 6 with benzoyl chloride afforded the pyrimido derivative 10 (60 %), while treatment of 7 with hydrazine hydrate or methyl amine at room temperature afforded the anthracene derivatives 8 and 9 in 50 and 52 % yield, respectively. The reactions are summarized in Scheme 1.
The structures of 7 -10 were confirmed by their 1 H, 13 C NMR and mass spectra and by elemental analyses. The chromene and aromatic protons showed a simi-lar pattern. In the 1 H NMR spectrum of 7, the singlet at δ = 9.01 ppm was assigned to the CH=N proton, while the singlets at δ = 5.80, 5.82, 5.88, and 5.49 ppm were attributed to 5-H of compounds 7 -10. The 13 C NMR spectra of 7 -10 contained similar resonance signals of the coumarin and aromatic carbon atoms. In the 13 C NMR spectrum of 7, C-2 resonated at δ = 162.3 ppm, while the resonances at δ = 154.9, 154.0 and 152.1 ppm were assigned to EtOHC =N, C-11a and C-6a carbon atoms. The chemical shifts at δ = 116.6, 116.4, 112.9 and 103.7 ppm were attributed to CN, C-7, C-10a and C-4a, respectively, while the resonance at δ = 83.2 ppm was assigned to C-3. In the 13 C NMR spectra of 8 -10, the chemical shifts between δ = 160.0 and 161.0 ppm were assigned to the C=O carbon atom of the coumarin moiety (C-6), while the resonances at δ = 158.0 ppm were assigned to C=NH carbon atom. C-7a, C-12a and C-13a appeared in the ranges δ = 141.7 -138.3, 154.0 and 152.0 -151.1 ppm. The signal at δ = 157.0 ppm was assigned to C-2 of 10, whereas the signals at δ = 133.3 and 135.3 ppm were attributed to the same atom of 8 and 9, respectively. C-5 appeared at δ = 31.4, 30.1 and 39.4 ppm, respectively. The signals of the other carbon atoms were fully analyzed (cf. Experimental Section).
Compound 9 has been selected for further NMR studies. From the gradient selected HMBC [42] spectrum, 5-H at δ H = 5.80 ppm showed two 2 J C,H couplings: one with C-4a at δ C = 75.0 ppm, and the other with C-5a at δ C = 105.0 ppm. Additionally, 5-H showed two 3 J C,H couplings wih C=O at δ C = 161.0 ppm and C=NH at δ C = 158.0 ppm. The structure of 7 was independently confirmed by a single-crystal X-ray diffraction analysis ( Fig. 1 and Experimental Section).
Next, treatment of 6 with acetic anhydride in dry pyridine for 3 h afforded the monoacetyl derivative 12, while the reaction with acetic anhydride in the presence of sulfuric acid for 10 h led to the pyrimidine derivative 13 in 55 and 75 % yield, respectively. An attempt to construct a third heterocyclic ring condensed with coumarin was successful via reaction of The mass spectral data were consistent with the structures of the synthesized compounds 11 -13. The structures of 11 -13 were assigned by the IR, 1 H, 13 C NMR and mass spectra. In the case of compounds 11 and 12, the 1 H NMR spectra were characterized by the presence of 4-H signals at δ = 5.49 and 5.77 ppm, while the 13 C NMR spectra exhibited signals at δ = 119.1 and 116.5 ppm, attributed to the CN carbons, respectively. The 13 C NMR spectrum of 13 exhibited a signal at δ = 161.6 ppm, attributed to the carbonyl group (C4=O) of the pyrimidine residue, with disappearance of the CN group signal, which supported the formation of a pyrimidine ring in 13. The signals at δ = 31.5 and 29.2 ppm were attributed to C-4 of 11 and 12, respectively, while the signal at δ = 30.0 ppm was assigned to C-5 of 13. The signals of the chromene and aromatic carbon atoms were fully analyzed (cf. Experimental Section). The structure of 13 was further confirmed by the gradient selected HMBC spectrum [42] . 5-H at δ = 5.75 ppm showed 3 J C,H couplings with the carbonyl groups of the pyrimidine ring (C4=O) and the chromene residue at δ = 161.9 and 159.8 ppm, respectively. Further, 2 J C,H couplings of H-5 with C-4a and C5a at δ = 102.3 and 106.4 ppm, respectively, were observed.
When mixtures of 6 and various β -ketoesters in toluene were stirred under reflux in the presence of SnCl 4 as a Lewis acid catalyst, the fused ring products 14 -17 were obtained in 54, 53, 53, and 56 % yield, respectively. Treatment of 6 with p-anisaldehyde in a dioxane-piperidine mixture gave the 2-(4-methoxybenzylideneamino)chromene-3-carbonitrile derivative 18 in 56 % yield (Scheme 3).
The 1 H NMR and 13 C NMR spectra of 14 -17 were in agreement with the suggested structures. The 1 H NMR spectra were characterized by the presence of the 5-H signal in the range δ = 6.07 -6.02 ppm, whereas the 13 C NMR spectra exhibited signals in the range δ = 39.5 -36.5 ppm, attributed to C-5. Compound 15 was selected for further NMR experiments. From a gradient HMBC NMR spectrum, a 3 J C,H coupling between OCH 2 protons at δ = 4.23 ppm and the carbonyl carbon atom at δ = 168.0 ppm of the ester moiety at C-3, was observed. Further, the protons of the 2-methyl group at δ = 2.49 ppm showed a 3 J C,H coupling with C-3 at δ = 114.0 ppm, the same protons revealved a 2 J C,H coupling with C-2 at δ = 139.2 ppm. Similarly, 5-H at δ = 6.02 ppm showed two 2 J C,H couplings with carbon atoms 4a and 5a at δ = 116.6 and 80.0 ppm, respectively, while the same proton demonstrated two 3 J C,H couplings with carbon atom 4 and carbonyl carbon atom C-6 at δ = 155.3 and 161.0 ppm, respectively (Fig. 2) . The mass spectra of the prepared compounds showed the correct molecular ions suggested by their molecular formulas. The 1 H and 13 C NMR spectra of 18 showed patterns similar to those of 12; the OMe, 5-H and HC=N protons appeared as three singlets at δ = 3.90, 6.09 and 9.41 ppm, respectively. The 13 C NMR spectrum of 18 was characterized by the presence of signal at δ = 161.0 ppm, assigned to HC=N together with the aromatic carbon atom (C-OMe).
In vitro anti-HIV activity
Compounds 6-11, 13-15 and 18 were tested for their in vitro anti-HIV-1 (strain III B ) and HIV-2 (strain ROD) activity in human (MT-4) cells. based on an MTT assay [43] . The results are summarized in Table 1 , in which the data for nevirapine (BOE/BIRG587) [44] and azidothymidine (DDN/AZT) [45] are included for comparison purposes.
Compounds 7, 8 and 13 were found to be the only compounds in the series inhibiting HIV-1 and HIV- 2 replication in cell cultures with EC 50 of > 2.27, > 4.84, and > 3.64 µg mL −1 , respectively, and a selectivity index of < 1.
In conclusion, the structure-activity relationship (SAR) suggested that the potency of compound 7 could be attributed to the presence of the cyano and formimidate groups in the 3-and 4-positions, respectively, of the pyrane ring. However, the anti-HIV activity and the selectivity of these compounds are too limited to perform extensive mode-of-action studies, and 7 might be considered as a new lead in the development of antiviral agents as a non-nucleoside reverse transcriptase inhibitor.
Conclusion
In this paper we have reported the synthesis and anti-HIV-1 and anti-HIV-2 evaluation of some pyranochromene and pyrimido pyrano-chromene derivatives. (7) is more active than other chromene derivatives. The synthesis of new analogs of these derivatives could lead to the discovery of more potent and selective compounds that will allow the elucidation of their molecular mode of action.
The preliminary in vitro anti-HIV data have demonstrated that the ethyl N-(3-cyano-4-(naphthalene-yl)-5-
oxo-4,5-dihydropyrano[3,2-c]chromen-2-yl) formimi- date
Experimental Section

General
Melting points are uncorrected and were determined on a Micro heating 
(1-Naphthylmethylene)malononitrile (1) and 2-amino-4-(naphthalen-1-yl)-5-oxo-4H,5H-pyrano-[3,2-c]chromene-3-carbonitrile (6)
These compounds were synthesized according to method described previously [46] .
Ethyl N-(3-cyano-4-(naphthalen-1-yl)-5-oxo-4,5-dihydropyrano[3,2-c]chromen-2-yl)formimidate (7)
A mixture of 6 (0.36 g, 1.0 mmol), triethyl orthoformate (2 mL) and acetic anhydride (10 mL) was heated under reflux for 8 h (TLC control). The reaction mixture was left to cool overnight, and the solid formed was recrystallized from dioxane to give 7 (0. [3 ,4 :5,6] pyrano [2,3- 
9-Amino-8-imino-7-(naphthalen-1-yl)-8,9-dihydrochromeno
d]pyrimidin-6-one (8)
To a solution of 7 (0.40 g, 1.0 mmol) in EOH (25 mL) a solution of hydrazine hydrate (5 mL) was added, and the mixture was stirred for 1 h, then allowed to stand overnight. Imino-9-methyl-7-(naphthalen-1-yl)-8,9 -dihydrochromeno [3 ,4 :5,6] pyrano [2,3-d] pyrimidin-6-one (9) To a solution of 7 (0.40 g, 1.0 mmol) in EtOH (25 mL) a solution of methylamine (0.03 g, 1.0 mmol) was added and the mixture stirred for 1 h. Then it was allowed to stand overnight. The precipitate formed was filtered, dried and recrystallized from dioxane to afford 9 (0. [3,2-c] [1, 2, 4] triazolo [1,5-a] quinoline-11-carbonitrile (11) To a solution of 6 (0.36 g, 1.0 mmol) in pyridine (20 mL), semicarbazide hydrochloride (0.11 g, 1.0 mmol) was added, and the mixture was heated under reflux for 6 h (TLC control). After cooling, the mixture was poured into cold water with stirring. The solid crude product was filtered, dried and recrystallized from dioxane to give 11 (0. 
8-
10-Amino-12-(naphthalen-1-yl)-2-oxo-3,12-dihydro-2H-pyrano
N-(3-Cyano-4-(naphthalen-1-yl)-5-oxo-4,5-dihydropyrano[3,2-c]chromen-2-yl)acetamide (12)
To a solution of 6 (0.36 g, 1.0 mmol) in dry pyridine (1.0 mL) was added acetic anhydride (3 mL), and the mixture was refluxed for 3 h (TLC monitoring). On cooling, a precipitate was separated and washed with EtOH. Recrystallization from dioxane afforded 12 (0. [3,4 : 5,6] pyrano- [2,3-d] pyrimidin -6,8-dione (13) A solution of 6 (0.36 g, 1.0 mmol) in acetic anhydride (10 mL) containting conc. H 2 SO 4 (5 mL) was heated under reflux for 10 h. A precipitate was formed after keeping the mixture at room temperature for 24 h, which was filtered and washed with water and EtOH. The product was recrystallized from EtOH to give 13 (0. [3 ,4 : 5,6 ]-pyrano [2,3-b] pyridine-9-carboxylate 14 -17
Methyl-7-(naphthalen-1-yl) chromeno
General preparation of alkyl 8-amino-(naphthalen-1-yl)-6-oxo-10-alkyl-6,7-dihydro-
To a stirred solution of ester (1.0 mmol) in dry toluene (20 mL) were added 6 (0.36 g, 1.0 mmol) and SnCl 4 (2 mL). The reaction mixture was stirred under argon at room temperature for 30 min and then heated under reflux for 6 h (TLC control). After cooling, the mixture was dispersed into water and adjusted to pH = 12 -13 with a saturated aq. solution of Na 2 CO 3 . The mixture was filtered, and the filterate was extracted with ethyl acetate (3×15 mL). The combined organic extracts were dried and evaporated to dryness to give a crude product. Recrystallization from dioxane afforded the desired product. 10-propyl-6,7-dihydrochromeno [3 ,4 : 5,6] pyrano [2,3-b] pyridine-9-carboxylate (14) From propyl 
Ethyl 8-amino-7-(naphthalen-1-yl)-6-oxo-
